V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330005787 | 330002748 | 1.65 | 0 | Disease modification (D) | null | 2014-10-03 | Capecitabine (14 days)+Carboplatin | N | N | 330024864 | CAV |
| 330005789 | 330002749 | null | 75 | Palliative (P) | 2016-11-28 | 2016-11-30 | OST Euramos 1 Closed Trial - M | N | N | 330024877 | VIDE |
| 330005790 | 330002750 | null | null | Adjuvant (A) | 2016-08-24 | 2016-08-24 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 330024880 | DE-ESCALATE TRIAL |
| 330005791 | 330002750 | 1.65 | 96 | Palliative (P) | 2013-08-31 | 2013-09-21 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 330024880 | UKALL XII |
| 330005792 | 330002751 | null | 93.8 | Palliative (P) | null | 2015-09-28 | AML 19 TRIAL | N | N | 330024888 | ETOPOSIDE |
| 330005793 | 330002752 | 0 | 66.4 | Adjuvant (A) | 2015-03-30 | 2015-03-30 | Azacitidine | Y | N | 330024889 | LIPOSOMAL DAUNORUBICIN |
| 330005794 | 330002753 | 1.7 | 67.8 | Curative (C) | 2016-08-24 | 2016-08-25 | IBRUTINIB | 02 | N | 330024892 | PEMBROLIZUMAB |
| 330005795 | 330002753 | 1.77 | 83.65 | Palliative (P) | 2015-10-24 | 2015-10-24 | Doxorubicin + Ifosfamide | null | null | 330024892 | CISPLATIN + DOX + ETOPOSIDE |
| 330005796 | 330002753 | null | 83 | Palliative (P) | 2013-04-05 | 2013-04-07 | ALL Int Guide A/B/C Maint Ph V | 02 | Y | 330024892 | PACLITAXEL |
| 330005797 | 330011506 | 0 | 87 | Curative (C) | 2013-01-06 | 2013-01-14 | Vincristine (weekly) | N | N | 330024906 | CARBOPLATIN + VINCRISTINE |
| 330005798 | 330011506 | 1.68 | 76 | Palliative (P) | 2014-10-07 | 2014-10-14 | FLAG + Idarubicin | 2 | N | 330024906 | VINBLASTINE |
| 330005799 | 330012724 | 0 | null | Curative (C) | 2013-08-08 | 2013-12-01 | Etoposide + Ifosfamide + HD Mtx | N | N | 330024909 | CISPLATIN + PEMETREXED |
| 330005800 | 330012724 | 1.83 | 102.3 | Adjuvant (A) | 2013-06-26 | 2013-07-10 | VIDE | N | Y | 330024909 | DOCETAXEL |
| 330005801 | 330012724 | 1.6 | 57.5 | Adjuvant (A) | 2017-12-02 | 2017-12-27 | MIFAMURTIDE | N | N | 330024909 | MIFAMURTIDE |
| 330005802 | 330013234 | 1.79 | 75.5 | Curative (C) | 2013-10-31 | 2013-11-06 | DOCETAXEL + GEMCITABINE | 02 | N | 330024914 | TEMOZOLOMIDE + RT |
| 330005803 | 330013234 | 1.83 | 17.8 | Curative (C) | 2015-03-02 | 2015-03-03 | FLAG | N | N | 330024914 | FCR |
| 330005804 | 330002754 | 1.7 | 76.5 | Palliative (P) | 2018-02-01 | 2018-02-01 | Vinblastine | N | N | 330024925 | CHLORAMBUCIL |
| 330005805 | 330002754 | null | 76.2 | Curative (C) | 2018-02-20 | 2018-03-24 | VAC | N | N | 330024925 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330005806 | 330002754 | 1.65 | 73.3 | Curative (C) | 2014-08-22 | 2014-08-31 | VIDE | N | N | 330024925 | CHLORAMBUCIL |
| 330005807 | 330002755 | null | 54.9 | Palliative (P) | 2016-10-15 | 2016-10-18 | ALL UKALL2011 Ind A Sht Dex (PAsp) | N | N | 330024939 | PAZOPANIB |
| 330005808 | 330002755 | 1.8 | 74.4 | Curative (C) | null | 2014-09-13 | Azacitidine | N | N | 330024939 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 330005811 | 330002756 | null | null | Curative (C) | null | 2015-01-26 | OCTREOTIDE | null | null | 330024944 | AML16 TRIAL |
| 330005812 | 330002757 | 1.82 | 67.6 | Curative (C) | 2015-10-27 | 2015-10-30 | POMALIDOMIDE | 02 | N | 330024946 | CHOP R |
| 330005814 | 330002759 | null | 43.6 | Disease modification (D) | 2014-01-09 | 2014-01-10 | OCTREOTIDE | N | N | 330024954 | EMA |
| 330005815 | 330002759 | 1.56 | 46.9 | Curative (C) | 2016-06-17 | 2016-07-08 | Docetaxel 100mg/m2 (21 day) | N | N | 330024954 | CHLORAMBUCIL |
| 330005816 | 330002759 | 1.65 | 7.6 | Palliative (P) | 2014-11-17 | 2014-12-10 | Topotecan (intravenous) | N | N | 330024954 | CVD |
| 330005817 | 330002759 | 1.8 | 86 | Palliative (P) | 2016-06-18 | 2016-06-22 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 330024954 | UKALL 2011 |
| 330005818 | 330002759 | null | null | null | 2013-05-12 | 2013-05-12 | Abiraterone | N | N | 330024954 | UKALL2014 |
| 330005819 | 330002759 | 1.62 | 153 | Palliative (P) | 2017-02-16 | 2017-03-09 | BEP 3 day | N | N | 330024954 | BEP |
| 330005820 | 330002759 | 1.66 | 56 | null | 2017-01-25 | 2017-01-31 | Dacarbazine | 02 | null | 330024954 | FEC |
| 330005821 | 330002760 | null | 62.9 | Palliative (P) | 2016-12-09 | 2017-01-02 | FLUDARABINE | N | N | 330024990 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 330005822 | 330002760 | 0 | 82.7 | Curative (C) | null | 2016-10-04 | CISPLATIN + VINORELBINE | null | null | 330024990 | TEMOZOLOMIDE + RT |
| 330005823 | 330002760 | 0 | 54.7 | Palliative (P) | 2016-07-22 | 2016-07-31 | Methotrexate Intrathecal (any age) | N | null | 330024990 | BEP |
| 330005824 | 330011509 | 1.74 | 51 | Palliative (P) | null | 2014-09-27 | Docetaxel | null | null | 330025006 | FLAG + IDARUBICIN |
| 330005825 | 330002761 | 1.57 | 93 | Adjuvant (A) | 2014-11-03 | 2014-11-03 | Hydroxycarbamide | 2 | N | 330025007 | DOCETAXEL + GEMCITABINE |
| 330005826 | 330002762 | null | 89.8 | Palliative (P) | 2013-12-06 | 2013-12-06 | IMATINIB | 2 | N | 330025010 | DOXORUBICIN + IFOSFAMIDE |
| 330005827 | 330002763 | 1.86 | 93.8 | Palliative (P) | 2016-03-27 | 2016-03-29 | BEP 5 Day | N | N | 330025013 | HYDROXYCARBAMIDE |
| 330005828 | 330002763 | 1.58 | 58.2 | Palliative (P) | 2016-07-26 | 2016-08-16 | IMATINIB | N | N | 330025013 | HYDROXYCARBAMIDE |
| 330005829 | 330002763 | 0 | 0 | Palliative (P) | 2017-04-16 | 2017-04-23 | AML17 TRIAL | 2 | N | 330025013 | CARBOPLATIN + RT |
| 330005830 | 330002764 | 0 | 92.4 | Curative (C) | 2017-11-21 | 2017-11-22 | CISPLATIN + VINORELBINE | 02 | N | 330025020 | AZACITIDINE |
| 330005831 | 330002764 | 1.8 | 113.8 | Palliative (P) | 2013-03-17 | 2013-03-17 | Cisplatin+Doxorubicin+Etoposide 28d | N | N | 330025020 | VIDE |
| 330005832 | 330002764 | 1.83 | 60 | Adjuvant (A) | 2014-03-13 | 2014-04-27 | ABVD | 02 | N | 330025020 | CHLORAMBUCIL |
| 330005833 | 330002765 | null | null | Neo-adjuvant (N) | 2014-11-30 | 2015-05-09 | Vinblastine | N | N | 330025032 | DOCETAXEL + GEMCITABINE |
| 330005834 | 330007508 | 1.68 | 111 | Neo-adjuvant (N) | 2015-03-05 | 2015-03-18 | CISPLATIN + DOXORUBICIN + ETOPOSIDE | N | N | 330025035 | CYTARABINE |
| 330005835 | 330010085 | 1.57 | null | null | null | 2014-01-22 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | null | null | 330025041 | PEMBROLIZUMAB |
| 330005836 | 330002766 | 1.75 | 92 | Curative (C) | 2016-06-14 | 2016-06-14 | Azacitidine | N | N | 330025043 | AML17 TRIAL |
| 330005837 | 330002767 | 1.65 | 32.8 | Adjuvant (A) | 2014-10-20 | 2015-06-25 | CHOP R | N | N | 330025046 | DACARBAZINE |
| 330005838 | 330002768 | null | 60.3 | Curative (C) | 2017-06-18 | 2017-06-18 | Gemcitabine + RT pancreas | N | N | 330025052 | BEP |
| 330005839 | 330002768 | null | null | null | 2016-02-25 | 2016-02-29 | BEP 5 Day | null | null | 330025052 | CISPLATIN + DOX + ETOPOSIDE |
| 330005840 | 330002768 | 1.8 | null | Palliative (P) | 2018-01-09 | 2018-01-09 | CAPECITABINE + CARBOPLATIN | N | N | 330025052 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |